Executive Board

Dr. Heribert Bohlen MD

heribert bohlen

PhD Chief Executive Officer

is co-founder and CEO of Axiogenesis. At the University hospital in Cologne he led the department of Immunology and experimental Immunotherapy. He designed and finalized numerous experimental clinical studies with bispecifc antibodies and novel cellular vaccines.

During his clinical duties he was responsible for the bone marrow transplantation and was a member of thestiring group of the German Hodgkin Study group. As scientist at the Free University Brussels and The University of Cologne he achieved several awards and is the author of over 80 peer reviewed publications. He is responsible for Research and Development at Axiogenesis.

Dr. Bernd Fronhoff

bernd fronhoff

Chief Financial Officer – Chief Operating Officer

is in charge of financial and operational affairs. He joined the company in 2001 and became shareholder in 2005. Before Axiogenesis, Bernd had been working in the TV- and Media-Industry covering Marketing, Sales and Corporate Management positions.


Nattermannallee 1, Bldg S20
50829 Cologne
Germany –  (Map)

600 W Germantown Pike, Suite 110
Plymouth Meeting, PA 19462
USA – (Map)


Orders: order@axiogenesis.com
Support: support@axiogenesis.com
Other: office@axiogenesis.com


Twitter:  |   LinkedIn:  |   Newsletter:  Subscribe Axiogenesis Newsletter


Phone (Main)
+49 221 99 88 18-0

Phone (US)
+1 844-511-6959

Fax + 49 221 99 88 18-10